These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12014812)

  • 1. Antisocial personality disorder and TC treatment outcomes.
    Messina NP; Wish ED; Hoffman JA; Nemes S
    Am J Drug Alcohol Abuse; 2002; 28(2):197-212. PubMed ID: 12014812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing antisocial personality disorder among substance abusers: the scid versus the MCMI-II.
    Messina N; Wish E; Hoffman J; Nemes S
    Am J Drug Alcohol Abuse; 2001 Nov; 27(4):699-717. PubMed ID: 11727884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminant efficiency of antisocial and borderline personality disorder criteria in Hispanic men with substance use disorders.
    Becker DF; Grilo CM; Anez LM; Paris M; McGlashan TH
    Compr Psychiatry; 2005; 46(2):140-6. PubMed ID: 15723032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generality of Psychopathy Checklist-Revised factors over prisoners and substance-dependent patients.
    McDermott PA; Alterman AI; Cacciola JS; Rutherford MJ; Newman JP; Mulholland EM
    J Consult Clin Psychol; 2000 Feb; 68(1):181-6. PubMed ID: 10710854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in the assessment of personality disorder and substance abuse using the Millon Clinical Multiaxial Inventory (MCMI-II).
    Flynn PM; McCann JT; Fairbank JA
    J Clin Psychol; 1995 May; 51(3):415-21. PubMed ID: 7560145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic community treatment for substance abusers with antisocial personality disorder.
    Messina NP; Wish ED; Nemes S
    J Subst Abuse Treat; 1999; 17(1-2):121-8. PubMed ID: 10435260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of the MCMI-III in a substance-abusing inpatient sample.
    Craig RJ; Olson R
    Psychol Rep; 1998 Dec; 83(3 Pt 2):1273-4. PubMed ID: 10079725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in antisocial aggressiveness during treatment in a hierarchical therapeutic community. A prospective study of personality changes.
    Ravndal E; Vaglum P
    Acta Psychiatr Scand; 1991 Dec; 84(6):524-30. PubMed ID: 1792926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correspondence of the MMPI-2 and MCMI-II in male substance abusers.
    Ward LC
    J Pers Assess; 1995 Apr; 64(2):390-3. PubMed ID: 7722864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment compliance in the trajectory of treatment progress among offenders.
    Sung H; Belenko S; Feng L
    J Subst Abuse Treat; 2001 Mar; 20(2):153-62. PubMed ID: 11306218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antisocial personality subtypes on drug abuse treatment response.
    King VL; Kidorf MS; Stoller KB; Carter JA; Brooner RK
    J Nerv Ment Dis; 2001 Sep; 189(9):593-601. PubMed ID: 11580002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopathy and antisocial personality disorder among alcoholic inpatients.
    Windle M
    J Stud Alcohol; 1999 May; 60(3):330-6. PubMed ID: 10371260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers.
    Cecero JJ; Ball SA; Tennen H; Kranzler HR; Rounsaville BJ
    J Nerv Ment Dis; 1999 Aug; 187(8):478-86. PubMed ID: 10463065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCMI-II personality disorders in recent-onset bipolar disorders.
    Turley B; Bates GW; Edwards J; Jackson HJ
    J Clin Psychol; 1992 May; 48(3):320-9. PubMed ID: 1602021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antisocial personality disorder diagnosis in substance abusers: problems and issues.
    Alterman AI; Cacciola JS
    J Nerv Ment Dis; 1991 Jul; 179(7):401-9. PubMed ID: 1869868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in personality characteristics in women treated in a therapeutic community.
    Schinka JA; Hughes PH; Coletti SD; Hamilton NL; Renard CG; Urmann CF; Neri RL
    J Subst Abuse Treat; 1999 Mar; 16(2):137-42. PubMed ID: 10023611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of the diagnostic criteria for antisocial personality disorder in substance abusers.
    Cacciola JS; Rutherford MJ; Alterman AI; Snider EC
    J Nerv Ment Dis; 1994 Sep; 182(9):517-23. PubMed ID: 8083681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor structure of the Millon Clinical Multiaxial Inventory (MCMI) with an offender sample.
    McCormack JK; Barnett RW; Wallbrown FH
    J Pers Assess; 1989; 53(3):442-8. PubMed ID: 2778613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality and psychopathology of drug addicts in Puerto Rico.
    Porrata JL; Rosa A
    Psychol Rep; 2000 Feb; 86(1):275-80. PubMed ID: 10778280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine users with antisocial personality improve HIV risk behaviors as much as those without antisocial personality.
    Compton WM; Cottler LB; Spitznagel EL; Ben Abdallah A; Gallagher T
    Drug Alcohol Depend; 1998 Feb; 49(3):239-47. PubMed ID: 9571388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.